Mc Adam, LLC Hepion Pharmaceuticals, Inc. Transaction History

Mc Adam, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$0.31 - $1.06 $0 - $1	1 Added 0.0%	62,169 $48,000
Q4 2022 Jan 27, 2023	SELL	$0.27 - $11.9 $0 - $11	-1 Reduced -0.0%	62,168 $71,000
Q1 2022 Apr 07, 2022	BUY	$0.93 - $1.29 $0 - $1	1 Added 0.0%	62,169 $80,000
Q4 2021 Jan 07, 2022	BUY	$1.14 - $1.58 $7,056 - $9,780	6,190 Added 11.06%	62,168 $71,000
Q2 2021 Aug 02, 2021	BUY	$1.56 - $2.26 $30,165 - $43,701	19,337 Added 52.77%	55,978 $86,000
Q1 2021 Apr 26, 2021	BUY	$1.77 - $2.98 $64,854 - $109,190	36,641 New	36,641 $67,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.